Results 41 to 50 of about 10,143,464 (406)

C-peptide: a predictor of cardiovascular mortality in subjects with established atherosclerotic disease [PDF]

open access: yes, 2017
Aim: Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Levels of C-peptide are increased in these patients and its role in the atherosclerosis progression was studied in vitro and in vivo over the past ...
Ballanti, Marta   +13 more
core   +1 more source

Use of a community advisory board to build equitable algorithms for participation in clinical trials: a protocol paper for HoPeNET

open access: yesBMJ Health & Care Informatics, 2022
Introduction Participation from racial and ethnic minorities in clinical trials has been burdened by issues surrounding mistrust and access to healthcare.
Nicole Farmer   +10 more
doaj   +1 more source

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

open access: yesBiomedicines, 2022
In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim
Arrigo F. G. Cicero   +8 more
doaj   +1 more source

Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus [PDF]

open access: yes, 2006
Background: Type 2 diabetes mellitus is associated with increased cardiovascular risk. One laboratory marker for cardiovascular risk assessment is high-sensitivity C-reactive protein (hsCRP).
Balkau   +33 more
core   +1 more source

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2020
Importance It remains uncertain whether the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduce cardiovascular risk. Objective To determine the effects on cardiovascular outcomes of a carboxylic acid formulation of EPA
Stephen J. Nicholls   +21 more
semanticscholar   +1 more source

Use of human PBMC to analyse the impact of obesity on lipid metabolism and metabolic status: a proof-of-concept pilot study

open access: yesScientific Reports, 2021
Peripheral blood mononuclear cells (PBMC) are widely used as a biomarker source in nutrition/obesity studies because they reflect gene expression profiles of internal tissues.
Andrea Costa   +7 more
doaj   +1 more source

Risk Factors for Long-Term Coronary Artery Calcium Progression in the Multi-Ethnic Study of Atherosclerosis. [PDF]

open access: yes, 2015
BackgroundCoronary artery calcium (CAC) detected by noncontrast cardiac computed tomography scanning is a measure of coronary atherosclerosis burden. Increasing CAC levels have been strongly associated with increased coronary events.
Blaha, Michael J   +7 more
core   +2 more sources

Effects of dalcetrapib in patients with a recent acute coronary syndrome [PDF]

open access: yes, 2012
In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events.
Abt, Markus   +18 more
core   +2 more sources

Cardiovascular and mortality risks in migrant South Asians with type 2 diabetes: are we winning the battle? [PDF]

open access: yes, 2017
Purpose of Review: We seek to describe the relationship between diabetes mellitus and cardiovascular risk in migrant South Asians compared to native white Europeans, and to determine the temporal change in this relationship over recent years.
Johns, Emma, Sattar, Naveed
core   +1 more source

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.

open access: yesEuropean Heart Journal, 2021
AIMS The aim of this study was to develop, validate, and illustrate an updated prediction model (SCORE2) to estimate 10-year fatal and non-fatal cardiovascular disease (CVD) risk in individuals without previous CVD or diabetes aged 40-69 years in Europe.
S. Hageman   +174 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy